Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.
Funding US-based microbiome therapy developer Vedanta Biosciences completed a $68m series D round yesterday that included a $25m investment from pharmaceutical firm Pfizer and additional cash from synthetic rubber producer JSR Corporation, healthcare services provider SymBiosis and Fosun Health Capital, a vehicle for conglomerate Fosun. Affiliates of Magnetar Capital led the round, which also featured…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.